A Phase 1 study of Abexinostat with Temozolomide in Recurrent Glioma
Recruiting Phase 1 NCT05698524
Study Description
A Study of Temodar With Abexinostat for Patients With Recurrent Brain Cancer (Glioma)
Study Details
- Registry ID:
- NCT05698524
- Conditions:
- Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Glioblastoma, Gliosarcoma
- Phase:
- Phase 1
- Target Enrollment:
- 24 participants
- Start Date:
- Age Range:
- 19–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
University of Nebraska Medical Center
Omaha, Nebraska, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.